[埃罗省（法国南部一省）的肾细胞癌：30年期间的结果]

[Renal cell carcinoma in the department of Hérault: Results over a 30 year period].

作者信息

Hutin M, Trétarre B, Gras C, Bessaoud F, Daurès J-P, Delbos O, Bringer J-P, Ayuso D, Thuret R, Azria D, Serre I, Brel D, Reis Borges R, Iborra F, Rébillard X

机构信息

Service d'urologie, Clinique Beau Soleil, 119, avenue de Lodève, 34070 Montpellier, France; Service d'urologie, Centre Hospitalier Intercommunal du Bassin de Thau, boulevard Camille Blanc, 34200 Sète, France.

Registre des Tumeurs de l'Hérault, 208, rue des Apothicaires, 34298 Montpellier Cedex 5, France.

出版信息

Prog Urol. 2021 Mar;31(3):175-182. doi: 10.1016/j.purol.2020.10.001. Epub 2020 Nov 5.

DOI:10.1016/j.purol.2020.10.001

PMID:33160850

Abstract

OBJECTIVE

The objective of the study was to determine the specificities of renal cell carcinoma (RCC) in the department of Herault using the Herault Tumor Registry over 30 years.

METHODS

Data of this study were obtained from the Herault cancer database. We analysed the evolution of RCC from 1987 to 2016, including the incidence, mortality, cancer pathology and staging at the moment of diagnosis. We compared our results with national and international data.

RESULTS

We identified 3769 newly diagnosed RCC: 2628 in men (69,7%) and 1141 in women (30,3%). In 2016, RCC was the 8th most frequent cancer, both genders combined, the 7th most frequent cancer in men and the 11th in women. New cases of RCC increased by 4.2 in men and 3.3 in women over the study period. The number of localised forms increased by 9% over 20 years. In 2016, the probability of having a RCC before the age of 75 was of 2.11% for a man and of 0.62% for a woman.

CONCLUSION

Over 30 years, the incidence rate of RCC increased in the department of Herault; however, mortality decreased over the same period. This analytical data should be improved by the development of the Registry of Herault Specialised in Onco-Urology (RHESOU).

LEVEL OF EVIDENCE

摘要

目的

本研究的目的是利用埃罗省肿瘤登记处的数据，确定30年来埃罗省肾细胞癌（RCC）的特异性。

方法

本研究数据来自埃罗省癌症数据库。我们分析了1987年至2016年肾细胞癌的演变情况，包括发病率、死亡率、癌症病理及诊断时的分期。我们将研究结果与国内和国际数据进行了比较。

结果

我们共识别出3769例新诊断的肾细胞癌患者：男性2628例（69.7%），女性1141例（30.3%）。2016年，肾细胞癌是男女合计第8大常见癌症，男性中第7大常见癌症，女性中第11大常见癌症。在研究期间，男性肾细胞癌新发病例增加了4.2例，女性增加了3.3例。20年间，局限性病例数量增加了9%。2016年，75岁前患肾细胞癌的概率男性为2.11%，女性为0.62%。